Leaflet CAL-D-VITA 600mg / 400UI chewable tablets


Indicated for: calcium deficiency; osteoporosis

Route of administration: oral

Substance: calcium carbonate + cholecalciferol (antacid + vitamin)

ATC: A11JBN1 (Alimentary tract and metabolism | Other vitamin products, combinations | Vitamins with minerals)

Calcium carbonate and colecalciferol (vitamin D3) are used together for the prevention and treatment of calcium and vitamin D deficiency, especially in patients at risk of osteoporosis. This combination helps maintain healthy bones and teeth.

Calcium is essential for the formation and maintenance of bones, while vitamin D3 enhances calcium absorption in the body. This treatment is often recommended for elderly individuals, postmenopausal women, or those with insufficient calcium and vitamin D intake.

The medication is available as chewable or effervescent tablets and should be taken as directed by a doctor. It is important to avoid overdosing, as it may lead to hypercalcemia.

Side effects may include nausea, constipation, or abdominal discomfort. In rare cases, allergic reactions or kidney stone formation may occur.

General data about CAL-D-VITA 600mg / 400UI

  • Substance: calcium carbonate + cholecalciferol
  • Date of last drug list: 01-09-2021
  • Commercial code: W67854001
  • Concentration: 600mg / 400UI
  • Pharmaceutical form: chewable tablets
  • Quantity: 60
  • Product type: original
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: DELPHARM GAILLARD - FRANTA
  • Holder: TEOFARMA S.R.L. - ITALIA
  • Number: 11626/2019/01
  • Shelf life: 18 months

Pharmaceutical forms available for calcium carbonate + cholecalciferol